Michael Schiffgens v. HHS - Tdap, Guillain-Barré Syndrome (2015)

Michael Schiffgens filed a petition alleging that a Tetanus-Diphtheria-Acellular Pertussis (Tdap) vaccine administered on September 6, 2011, caused him to develop Guillain-Barré Syndrome (GBS). The petition was filed on September 10, 2014.

Respondent denied that the vaccine caused or aggravated the injury. However, the parties reached a stipulation for damages.

The court adopted the stipulation, awarding Michael Schiffgens a total of $159,770. This amount included $129,385.20 as a lump sum payment to Schiffgens and $443.69 to reimburse a Medicaid lien, payable jointly to Schiffgens and the Commonwealth of Massachusetts.

Additionally, a separate decision on October 26, 2015, awarded $30,000.00 in attorneys' fees and costs, payable jointly to Schiffgens and his counsel. The Tdap vaccine is listed on the Vaccine Injury Table, and the parties agreed to settle the case, with judgment entered accordingly.